AstraZeneca completes Phase 1 laroprovstat/ezetimibe bioavailability study in healthy adultsWeekly roundup, 2 itemsacalabrutinibAstraZeneca
Novartis: Myfortic label update approved; M.D. Anderson posts endometrial trial resultsWeekly roundup, 6 itemsabelacimabDDY391
AstraZeneca registers Phase III bladder cancer trial; joins Natera-led breast cancer studyWeekly roundup, 5 itemsAstraZenecaAZD6489
Sign inSign in